0001225208-11-027050.txt : 20111229
0001225208-11-027050.hdr.sgml : 20111229
20111229122715
ACCESSION NUMBER: 0001225208-11-027050
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20100306
FILED AS OF DATE: 20111229
DATE AS OF CHANGE: 20111229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celentano John E
CENTRAL INDEX KEY: 0001346102
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 111285744
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: 777 SCUDDERS MILL ROAD
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4/A
1
doc4a.xml
X0304
4/A
2010-03-06
2010-03-09
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001346102
Celentano John E
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
Pres Emerging Mkts & Asia-Pac
Restricted Stock Units
0.0000
2010-03-06
4
M
0
4256.0000
0.0000
D
2010-03-06
Common Stock, $0.10 par value
4256.0000
8514.0000
D
Each restricted stock unit converts into one share of common stock upon vesting.
One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock.
This Form 4 is being amended to reflect the correct number of derivative securities beneficially owned following this reported transaction. The number of derivative securities beneficially owned following the transaction reported for this award in a Form 4 filed on March 8, 2011 was also reported incorrectly.
Exhibit 24 - Power of Attorney
/s/ Robert J. Wollin, attorney-in-fact for John E. Celentano
2011-12-29
EX-24
2
celentano_poa.txt
Exhibit 24
POWER OF ATTORNEY
I, John E. Celentano, Senior Vice President, Human Resources,
Public Affairs and Philanthropy of Bristol-Myers Squibb Company (the "Company"),
a corporation duly organized and existing under the laws of the State of
Delaware, in the United States of America, and having its principal place of
business at 345 Park Avenue, New York, New York, do hereby constitute and
appoint each of Sandra Leung, Katherine R. Kelly, and Robert J. Wollin,
individually, as my lawful attorney-in-fact and in my name, place and stead
to execute and deliver any and all documents relating to insider reporting
requirements under Section 16 of the Securities Exchange Act of 1934, with
respect to securities issued by the Company, including, without limitation
the execution and filing of all Forms 3, 4 and 5, and to take such other
action, as such attorney considers necessary or appropriate, to effectuate
such transactions. This Power of Attorney shall remain in full force and
effect until I am no longer required to file Forms 3, 4, and 5 with respect
to securities issued by the Company, unless earlier revoked.
IN WITNESS WHEREOF, I have executed this Power of Attorney on this
21st day of September, 2011.
/s/ John E. Celentano
John E. celentano